Chronic treatment with otilonium bromide induces changes in L-type Ca2+channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coat

Autor:	Paolo Santicioli, Maria-Simonetta Faussone-Pellegrini, Chiara Traini, Gianluca Cipriani, Stefano Evangelista, M. G. Vannucchi
Rok vydání:	2013
Předmět:	Agonist medicine.medical_specialty biology Endocrine and Autonomic Systems Physiology medicine.drug_class Gastroenterology Substance P Nitric oxide Nitric oxide synthase chemistry.chemical_compound Endocrinology chemistry Internal medicine biology.protein medicine Myocyte Channel blocker Otilonium bromide Receptor
Zdroj:	Neurogastroenterology & Motility. 25:e728-e739
ISSN:	1350-1925
DOI:	10.1111/nmo.12197
Popis:	Background Otilonium bromide (OB) is a quaternary ammonium derivative used for the treatment of intestinal hypermotility and is endowed with neurokinin2 receptor (NK2r) antagonist and Ca2+channel blocker properties. Therefore, the possibility that OB might play a role in the neurokinin receptor/Substance-P/nitric oxide (NKr/SP/NO) circuit was investigated after chronic exposition to the drug. Methods Rats were treated with OB 2–20 mg kg−1 for 10 and 30 days. In the proximal colon, the expression and distribution of muscle NOsynthase 1 (NOS1), NK1r, NK2r, SP and Cav 1.2 subunit (for L-type Ca2+channel) and the spontaneous activity and stimulated responses to NK1r and NK2r agonists were investigated. Key Results Immunohistochemistry showed a redistribution of NK1r and L-type Ca2+channel in muscle cells with no change of NK2r at 30 days, a significant increase in muscle NOS1 expression at 10 days and a significant decrease in the SP content early in the ganglia and later in the intramuscular nerve fibers. Functional studies showed no change in spontaneous activity but a significant increase in maximal contraction induced by NK1r agonist. Conclusions & Inferences Chronic exposition to OB significantly affects the NKr/SP/NO circuit. The progressive decrease in SP-expression might be the consequence of the persistent presence of OB, the increase of NOS1 expression in muscle cells at 10 days in an attempt to guarantee an adequate NO production, and, at 30 days, the redistribution of the L-type Ca2+channel and NK1r as a sign to compensate the drug channel block by re-cycling both of them. The physiological data suggest NK1r hypersensitivity.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::83228f4e4714bef716979fb3e3487d5b https://doi.org/10.1111/nmo.12197 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.